PlusPedia wird derzeit technisch modernisiert. Aktuell laufen Wartungsarbeiten. Für etwaige Unannehmlichkeiten bitten wir um Entschuldigung; es sind aber alle Artikel zugänglich und Sie können PlusPedia genauso nutzen wie immer.

Neue User bitte dringend diese Hinweise lesen:

Anmeldung - E-Mail-Adresse Neue Benutzer benötigen ab sofort eine gültige Email-Adresse. Wenn keine Email ankommt, meldet Euch bitte unter NewU25@PlusPedia.de.

Hinweis zur Passwortsicherheit:
Bitte nutzen Sie Ihr PlusPedia-Passwort nur bei PlusPedia.
Wenn Sie Ihr PlusPedia-Passwort andernorts nutzen, ändern Sie es bitte DORT bis unsere Modernisierung abgeschlossen ist.
Überall wo es sensibel, sollte man generell immer unterschiedliche Passworte verwenden! Das gilt hier und im gesamten Internet.
Aus Gründen der Sicherheit (PlusPedia hatte bis 24.07.2025 kein SSL | https://)

Bei PlusPedia sind Sie sicher: – Wir verarbeiten keine personenbezogenen Daten, erlauben umfassend anonyme Mitarbeit und erfüllen die Datenschutz-Grundverordnung (DSGVO) vollumfänglich. Es haftet der Vorsitzende des Trägervereins.

PlusPedia blüht wieder auf als freundliches deutsches Lexikon.
Wir haben auf die neue Version 1.43.3 aktualisiert.
Wir haben SSL aktiviert.
Hier geht es zu den aktuellen Aktuelle Ereignissen

Polycystisches Ovar: Unterschied zwischen den Versionen

Aus PlusPedia
Zur Navigation springen Zur Suche springen
VisuellWikitext
Ossip Groth (Diskussion | Beiträge)
5.526 Bearbeitungen
Die Seite wurde neu angelegt: „miniatur|Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Siehe auch''' | align="left" width="800" | |- | bgcolor="#d…“
 
Ossip Groth (Diskussion | Beiträge)
5.526 Bearbeitungen
KKeine Bearbeitungszusammenfassung
 
Zeile 6: Zeile 6:
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''
| align="left" width="800" |
| align="left" width="800" |
<ref name="PMID10858183">The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12):989-93 (2000) PMID 10858183 </ref><ref name="PMID12882878">Diabetes issues in women and children: polycystic ovary syndrome. Diabetes Care 26(8):2457-63 (2003) PMID 12882878 </ref><ref name="PMID16728533">Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154(6):763-75 (2006) PMID 16728533 </ref><ref name="PMID15096648">Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) 229(5):369-77 (2004) PMID 15096648 </ref><ref name="PMID19126632">Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab 94(1):35-7 (2009) PMID 19126632 </ref><ref name="PMID18987279">Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 93(11):4218-20 (2008) PMID 18987279 </ref><ref name="PMID18178908">Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 93(1):34-6 (2008) PMID 18178908 </ref><ref name="PMID18056778">Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92(12):4546-56 (2007) PMID 18056778 </ref><ref name="PMID17284617">Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 92(4):1209-16 (2007) PMID 17284617 </ref><ref name="PMID17179197">Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787-96 (2007) PMID 17179197 </ref><ref name="PMID16940456">Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237-45 (2006) PMID 16940456 </ref><ref name="PMID16522691">Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660-6 (2006) PMID 16522691 </ref><ref name="PMID16492691">Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(5):1741-7 (2006) PMID 16492691 </ref><ref name="PMID16418211">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91(3):781-5 (2006) PMID 16418211 </ref><ref name="PMID16418209">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91(3):786-9 (2006) PMID 16418209 </ref><ref name="PMID16368745">Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941-5 (2006) PMID 16368745 </ref><ref name="PMID16263814">Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 91(1):22-4 (2006) PMID 16263814 </ref><ref name="PMID15623819">Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929-35 (2005) PMID 15623819 </ref><ref name="PMID15472165">Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89(10):4797-800 (2004) PMID 15472165 </ref><ref name="PMID14602740">Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 88(11):5137-44 (2003) PMID 14602740 </ref><ref name="PMID11061494">Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? J Clin Endocrinol Metab 85(10):3520-5 (2000) PMID 11061494 </ref><ref name="PMID10372683">Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897-9 (1999) PMID 10372683 </ref><ref name="PMID9626128">Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976-87 (1998) PMID 9626128 </ref><ref name="PMID1556225">ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? J Clin Pathol 45(3):188-92 (1992) PMID 1556225 </ref><ref name="PMID12098657">Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1-5 (2002) PMID 12098657 </ref><ref name="PMID18480528">Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54(2):115-25 (2008) PMID 18480528 </ref><ref name="PMID15235215">Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50(2):140-4 (2004) PMID 15235215 </ref><ref name="PMID10379878">Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 13(6):800-5 (1999) PMID 10379878 </ref>
<ref name="PMID10858183">The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12):989-93 (2000) PMID 10858183 </ref><ref name="PMID12882878">Diabetes issues in women and children: polycystic ovary syndrome. Diabetes Care 26(8):2457-63 (2003) PMID 12882878 </ref><ref name="PMID16728533">Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154(6):763-75 (2006) PMID 16728533 </ref><ref name="PMID15096648">Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) 229(5):369-77 (2004) PMID 15096648 </ref><ref name="PMID19126632">Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab 94(1):35-7 (2009) PMID 19126632 </ref><ref name="PMID18987279">Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 93(11):4218-20 (2008) PMID 18987279 </ref><ref name="PMID18178908">Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 93(1):34-6 (2008) PMID 18178908 </ref><ref name="PMID18056778">Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92(12):4546-56 (2007) PMID 18056778 </ref><ref name="PMID17284617">Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 92(4):1209-16 (2007) PMID 17284617 </ref><ref name="PMID17179197">Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787-96 (2007) PMID 17179197 </ref><ref name="PMID16940456">Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237-45 (2006) PMID 16940456 </ref><ref name="PMID16522691">Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660-6 (2006) PMID 16522691 </ref><ref name="PMID16492691">Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(5):1741-7 (2006) PMID 16492691 </ref><ref name="PMID16418211">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91(3):781-5 (2006) PMID 16418211 </ref><ref name="PMID16418209">Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91(3):786-9 (2006) PMID 16418209 </ref><ref name="PMID16368745">Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941-5 (2006) PMID 16368745 </ref><ref name="PMID16263814">Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 91(1):22-4 (2006) PMID 16263814 </ref><ref name="PMID15623819">Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929-35 (2005) PMID 15623819 </ref><ref name="PMID15472165">Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89(10):4797-800 (2004) PMID 15472165 </ref><ref name="PMID14602740">Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 88(11):5137-44 (2003) PMID 14602740 </ref><ref name="PMID11061494">Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? J Clin Endocrinol Metab 85(10):3520-5 (2000) PMID 11061494 </ref><ref name="PMID10372683">Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897-9 (1999) PMID 10372683 </ref><ref name="PMID9626128">Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976-87 (1998) PMID 9626128 </ref><ref name="PMID1556225">ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? J Clin Pathol 45(3):188-92 (1992) PMID 1556225 </ref><ref name="PMID12098657">Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1-5 (2002) PMID 12098657 </ref><ref name="PMID18480528">Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54(2):115-25 (2008) PMID 18480528 </ref><ref name="PMID15235215">Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50(2):140-4 (2004) PMID 15235215 </ref><ref name="PMID10379878">Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 13(6):800-5 (1999) PMID 10379878 </ref><ref name="PMID15561799">The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26(2):251-82 (2005) PMID 15561799 </ref>
|-
|-
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''

Aktuelle Version vom 16. April 2010, 19:28 Uhr

Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

Bibliographie

  1. ↑ The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132(12):989-93 (2000) PMID 10858183
  2. ↑ Diabetes issues in women and children: polycystic ovary syndrome. Diabetes Care 26(8):2457-63 (2003) PMID 12882878
  3. ↑ Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154(6):763-75 (2006) PMID 16728533
  4. ↑ Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood) 229(5):369-77 (2004) PMID 15096648
  5. ↑ Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab 94(1):35-7 (2009) PMID 19126632
  6. ↑ Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab 93(11):4218-20 (2008) PMID 18987279
  7. ↑ Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality. J Clin Endocrinol Metab 93(1):34-6 (2008) PMID 18178908
  8. ↑ Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92(12):4546-56 (2007) PMID 18056778
  9. ↑ Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 92(4):1209-16 (2007) PMID 17284617
  10. ↑ Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787-96 (2007) PMID 17179197
  11. ↑ Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91(11):4237-45 (2006) PMID 16940456
  12. ↑ Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91(5):1660-6 (2006) PMID 16522691
  13. ↑ Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91(5):1741-7 (2006) PMID 16492691
  14. ↑ Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91(3):781-5 (2006) PMID 16418211
  15. ↑ Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91(3):786-9 (2006) PMID 16418209
  16. ↑ Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91(3):941-5 (2006) PMID 16368745
  17. ↑ Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? J Clin Endocrinol Metab 91(1):22-4 (2006) PMID 16263814
  18. ↑ Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90(4):1929-35 (2005) PMID 15623819
  19. ↑ Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. J Clin Endocrinol Metab 89(10):4797-800 (2004) PMID 15472165
  20. ↑ Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab 88(11):5137-44 (2003) PMID 14602740
  21. ↑ Metabolic lessons from the study of young adolescents with polycystic ovary syndrome--is insulin, indeed, the culprit? J Clin Endocrinol Metab 85(10):3520-5 (2000) PMID 11061494
  22. ↑ Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84(6):1897-9 (1999) PMID 10372683
  23. ↑ Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976-87 (1998) PMID 9626128
  24. ↑ ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated? J Clin Pathol 45(3):188-92 (1992) PMID 1556225
  25. ↑ Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 174(1):1-5 (2002) PMID 12098657
  26. ↑ Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54(2):115-25 (2008) PMID 18480528
  27. ↑ Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 50(2):140-4 (2004) PMID 15235215
  28. ↑ Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 13(6):800-5 (1999) PMID 10379878
  29. ↑ The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26(2):251-82 (2005) PMID 15561799

Andere Lexika

Abgerufen von „https://h.suprapedia.de/w/index.php?title=Polycystisches_Ovar&oldid=44408“